Stockreport

Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company

Axon Enterprise, Inc.  (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.axovant.com/investors/sec-filings
PDF Transition of small molecule expertise to Arvelle completes transformation of Axovant into a company focused exclusively on gene therapiesAxovant will receive a preferre [Read more]